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A novel Golgi-localisation domain shared by a class of coiled-coil
peripheral membrane proteins
Lars Kjer-Nielsen, Rohan D. Teasdale, Catherine van Vliet and Paul A. Gleeson
The mechanism by which peripheral membrane proteins
are targeted to the cytoplasmic face of the Golgi
apparatus is poorly understood. Previously, we have
identified a carboxy-terminal domain of the trans-Golgi-
network (TGN) protein p230 that is responsible for Golgi
localisation [1]. Here, we report the identification of a
similar Golgi-localisation domain (GLD, also termed the
‘GRIP’ domain — see the paper by Munro and Nichols
elsewhere in this issue) in a family of putative peripheral
membrane proteins from lower and higher eucaryotes.
The majority of family members have a domain structure
similar to that of p230, with extensive coiled-coil regions
(>80%) and the potential GLD located in a non-coiled-
coil domain at the carboxyl terminus. Previously
reported proteins in this family include human golgin-97
and Saccharomyces cerevisiae Imh1p. By constructing
chimeric cDNAs encoding carboxy-terminal regions of
these family members fused to green fluorescent
protein (GFP), we have directly demonstrated that the
GLD of p230, golgin-97, the newly identified human
protein GCC1p and yeast Imh1p functions as a Golgi-
targeting domain in transfected mammalian cells. Site-
directed mutagenesis of the GLDs identified two
conserved aromatic residues that are critical for the
function of this targeting domain. Endogenous p230 was
displaced from the Golgi membranes in transfected cells
expressing high levels of GFP fused to the GLD of either
p230 or golgin-97, indicating that different GLDs interact
with similar membrane determinants. Thus, we have
identified a family of coiled-coil proteins that share a
domain shown to be sufficient for the localisation of
peripheral membrane proteins to the Golgi apparatus.
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Results and discussion
The peripheral membrane protein p230 contains extensive
coiled-coil regions, and is localised to the cytoplasmic side
of TGN membranes as well as to non-clathrin-coated vesi-
cles budding from the TGN [2–4]. We have shown that the
non-coiled-coil carboxy-terminal domain of p230 is respon-
sible for Golgi localisation [1]. Within the 98 amino-acid
carboxy-terminal domain of p230, a minimum stretch of 42
residues was identified that displayed a Golgi-targeting
sequence; however, the amino acids flanking this ‘minimal
targeting sequence’ greatly increased the efficiency of
Golgi targeting [1], possibly as a result of increased accessi-
bility and/or proper folding of the targeting sequence. The
sequence of the 98 amino-acid carboxy-terminal domain of
p230 was used in a  search of sequences in a variety of data-
bases. Eight full-length sequences were identified that
showed significant relationship to the p230 GLD. Strik-
ingly, seven of these proteins are predicted to contain very
extensive (>80%) coiled-coil domains, similar to p230
(Figure 1b). All the GLDs were located in a carboxy-termi-
nal position, as for the p230 GLD, supporting the possibil-
ity that they have a similar function. The alignment of the
relevant sequences of these proteins is shown in Figure 1a.
Notably, the similarity in sequence was observed only
within the 42 amino-acid minimal targeting sequence of
p230 (Figure 1a). No sequence similarity was observed in
the sequences flanking this 42-residue stretch.
Sequences identified with coiled-coil domains include
three additional human proteins, one from S. cerevisiae,
and three from Caenorhabditis elegans. The human
sequences include the peripheral Golgi-membrane
protein golgin-97 [5] and two putative proteins, GCC1p
and KIAA0336. These three proteins have approximately
60% sequence similarity to p230 within the 42 amino-acid
core of the GLD. One of the proteins is derived from the
DNA cosmid sequence, g1572c101 (Genbank accession
number AC000357), and is predicted to encode a protein
of 633 amino acids (referred to as GCC1p for Golgi-
localised coiled-coil protein). The other human protein,
KIAA0336 (Genbank accession number AB002334), is
predicted to encode a protein of 1583 amino acids. The
lack of putative transmembrane domains in GCC1p and
KIAA0336 is consistent with them being peripheral mem-
brane proteins. S. cerevisiae Imh1p, a predicted protein of
912 amino acids with extensive coiled-coil domains, also
contains a potential GLD at its carboxyl terminus. Imh1p
was identified as a suppressor of a temperature-sensitive
yeast strain that lacks the functional small GTPase Rab6
homologue, Ypt6p [6]. The phenotype of the YPT6 defec-
tive strain includes defects in carboxypeptidase Y matura-
tion. The ability of Imh1p to suppress these defects
suggests that it can influence the secretory pathway,
perhaps through Rab6. Finally, three predicted open-
reading frames from C. elegans that were identified within
the GLD family (CE00321, CE03434, CE03988) also have
extensive coiled-coil domains (Figure 1b). Another
sequence that had a GLD was also identified but this
protein lack coiled-coil domains. Ran-binding protein 2α
(RanBP2α), a recently described protein encoded by a
member of the RanBP2 gene cluster [7], has a GLD at the
carboxyl terminus which is absent in RanBP2. Interest-
ingly, the GLD sequence of RanBP2α is almost identical
to the GLD of KIAA0336, suggesting a gene duplication
event. Because RanBP2α does not have regions of coiled-
coil structure, it appears that GLDs are not restricted to
proteins containing extensive coiled-coil domains.
To test whether the domains homologous to the p230 can
GLD act as Golgi-targeting sequences, we made chimeric
cDNAs encoding the non-coiled-coil carboxy-terminal
domains of golgin-97 (87 amino acids), human GCC1p (70
amino acids) or Imh1p (86 amino acids) fused to the
carboxyl terminus of GFP. COS cells were transfected with
these constructs and with GFP–p230-GLD for comparison.
Significantly, the resulting fusion proteins were all localised
to the Golgi (Figure 2), as indicated by the concentrated
juxtanuclear fluorescence; the three human-derived
sequences, GFP–p230-GLD, GFP–golgin-97-GLD and
GFP–GCC1p-GLD, were all efficiently localised to the
Golgi region of transfected COS cells (Figure 2a–c). The
yeast-derived sequence, GFP–Imh1p-GLD, was also
localised to the Golgi region, albeit less efficiently than the
other constructs (Figure 2d,e), indicating that the GLDs are
functionally conserved between yeast and mammalian cells.
In contrast, wild-type GFP was distributed in the cytoplasm
and nucleus of transfected COS cells (Figure 2f), consistent
with previous findings [8]. Endogenous p230 was detected
in the GFP-expressing cells with an affinity-purified human
anti-p230 antibody that recognises epitopes outside the
carboxy-terminal domain. Staining of transfected COS cells
expressing low levels of the GFP fusion protein with the
human anti-p230 antibodies revealed that, in each case, the
GFP fusion protein co-localised with endogenous p230,
confirming the Golgi location of the GFP fusion proteins
(data not shown).
Sequence comparisons revealed that the only region that
is well conserved throughout all members of the family of
coiled-coil proteins lies near the amino terminus of the
minimum targeting sequence of p230 (Figure 1a). In par-
ticular, a tyrosine at position 4 of the minimum targeting
sequence is the only residue conserved throughout the
entire family (Figure 1a). To determine whether this con-
served tyrosine is required for the GLD to act as a target-
ing signal, this residue was replaced with alanine in
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Figure 2
GFP fusion proteins containing four different GLDs are targeted to the
Golgi apparatus. Confocal fluorescent images of paraformaldehyde-
fixed transfected COS cells expressing (a) GFP–p230-GLD,
(b) GFP–golgin-97-GLD, (c) GFP–GCC1p-GLD, (d,e) GFP–Imh1p-
GLD and (f) wild-type GFP.
(a)
(b)
(c)
(d)
(f)
(e)
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Figure 1
A family of coiled-coil proteins that have a similar Golgi-localisation
domain of p230. (a) Alignment of sequences with the minimum
Golgi-targeting sequence of p230. The number at the end of each
sequence refers to the position of the carboxy-terminal residue in the
polypeptide chain of the protein. The conserved aromatic residues at
positions 4 and 12 are in bold. The asterisk indicates identity, and
single and double dots represent degrees of similarity. See text for
details of proteins. (b) Domain structure of the family members
showing protein sequences predicted to form coiled-coils (grey) and
potential GLDs (black).
            :  *::::.  ::               .:  : ..   :   :
p230        EFEYLRKVLFEYM-----MGRETKTMAKVITTVLKFPDDQTQKI 
Golgin-97   NFEYLKHVVLKFMSCR---ESEAFHLIKAVSVLLNFSQEEENML 
GCC1p       NLEYLKNIIYRFLTLP--DSLGRQQTLTAILTILHFSPEEKQVI 
KIAA0336    NLEYLKNVLLQFIFLK--PGSERERLLPVINTMLQLSPEEKGKL 
Imh1p       KIAYIKNVLLGFLEHK----EQRNQLLPVISMLLQLDSTDEKRL 
CE00321     NMEYLKNVFVQFLKPE-SVPAERDQLVIVLQRVLHLSPKEVEIL 
CE03434     EAEYLRNVLYRYMTNRESLGKESVTLARVIGTVARFDESQMKNV 
CE03988     EIDYLRNIFTQFLHSMGSPNAASKAILKAMGSVLKVPMAEMKII 
Coiled-coil domain(b)
(a)
p230 1 2228
GCC1p 1 633
Golgin-97 1 767
1 912Imh1p
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GFP–p230-GLD by site-directed mutagenesis. When the
mutated GFP–p230-GLD construct was expressed in
COS cells, the resulting fusion protein was no longer tar-
geted to the Golgi, but was localised throughout the cyto-
plasm (Figure 3b). In contrast, substitution of the
conserved tyrosine for phenylalanine did not significantly
decrease the efficiency with which GFP–p230-GLD was
localised to the Golgi (Figure 3c), indicating a require-
ment for an aromatic residue at this position. The GFP
fusion proteins were stable in transfected cells, as indi-
cated by the presence of fluorescence in each case and by
immunoblotting experiments, which demonstrated that
the mutated GFP fusion proteins were the expected size
and were present at similar levels as unmutated
GFP–p230-GLD. Substitution of the conserved tyrosine
residue for alanine in another GLD, namely that of
GCC1p, also resulted in a complete loss of Golgi targeting
of the relevant GFP fusion protein (data not shown), con-
firming the importance of this residue. Immunoprecipita-
tion experiments demonstrated that GFP-p230-GLD was
not phosphorylated (data not shown), a result consistent
with the requirement for an aromatic residue, rather than
tyrosine specifically, at this position.
In addition to the conserved tyrosine at position 4, a second
conserved aromatic residue (tyrosine or phenylalanine) is
also present at position 12 of the minimum targeting
sequence (Figure 1a). In p230, the aromatic residue at posi-
tion 12 is tyrosine, and again substitution of this tyrosine for
alanine in the GLD of p230 resulted in the loss of Golgi
localisation of the GFP fusion protein (Figure 3d,e). The
abolition of Golgi targeting by single amino-acid
substitutions supports the conclusion that these carboxy-
terminal domains contain a specific Golgi-targeting
sequence. Furthermore, as the two critical aromatic
residues are separated within the sequence, the result indi-
cates that the targeting signal does not consist of a short dis-
crete amino-acid sequence. The complex nature of the
targeting signal is also demonstrated by the previous obser-
vation that Golgi localisation of the GFP–p230 fusion
protein was abolished when blocks of six alanine substitu-
tions were incorporated anywhere along the 42 amino-acid
minimum targeting stretch [1]. Taken together, these
results indicate the importance of two conserved aromatic
residues, together with the overall conformation of the
42 amino-acid minimum targeting sequence, in conferring
the ability of the GLD to act as a targeting domain.
Previously, we demonstrated that GFP–p230-GLD was
able to displace endogenous p230 from Golgi membranes
when present at high levels in transfected cells [1]. The
question then arises as to whether the different family
members are recruited to Golgi membranes through the
same or different membrane structures that recruit p230.
Therefore, we analysed the ability of the GLD of golgin-
97 to compete with endogenous p230 for Golgi binding. In
COS cells expressing high levels of GFP–golgin-97-GLD,
the fusion protein was associated not only with the Golgi
region but was also detected throughout the cytoplasm,
indicating that Golgi binding was saturated (Figure 4). In
these cells expressing high levels of GFP–golgin-97-GLD,
very little endogenous p230 was detected in the Golgi
region, indicating that the GFP fusion protein was capable
of displacing endogenous p230 from Golgi membranes, in
a manner similar to that observed with GFP–p230-GLD
(Figure 4). In contrast, endogenous p230 was not dis-
placed from the Golgi in COS cells expressing high levels
of mutated GFP–p230-GLD, with the tyrosine at position
4 substituted with alanine (Figure 4). Furthermore, in
cells expressing high levels of GFP–golgin-97-GLD the
localisation of the Golgi markers β-COP and γ-adaptin was
similar to that of non-transfected cells, indicating that the
Golgi structure was intact in these transfected cells (data
not shown). This result demonstrates that the GLDs of
golgin-97 and p230 may associate with the same Golgi
target structure(s). Given that p230 is restricted to the
membranes of the TGN [4], these results suggest that
golgin-97 is also localised to TGN membranes.
The localisation and behaviour of p230 suggests a role in
vesicular transport [4]. Proteins with extensive coiled-coil
domains, such as p115 and Uso1p, have been implicated
in the docking or tethering of vesicles to target mem-
branes [9–11] and it is possible that the family of mol-
ecules identified here may share a similar function. It is of
Figure 3
Conserved aromatic residues of the GLD are required for Golgi
localisation. Confocal fluorescent images of paraformaldehyde-fixed
transfected COS cells expressing (a) GFP–p230-GLD, or GFP–p230-
GLD with the tyrosine at position 4 of the minimum targeting sequence
(see Figure 1a) substituted with (b) alanine or (c) phenylalanine, or
(d,e) GFP–p230-GLD with the tyrosine at position 12 of the minimum
targeting sequence substituted with alanine.
(a) (b)
(c) (d)
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interest that Imh1p was identified as a suppressor of a
temperature-sensitive yeast mutant that lacks a functional
Rab6 homologue [6], and that deletion of both Imh1p
(Sys3p) and yeast Rab6 greatly exacerbates the trafficking
defect [12]. Significantly, Rab6 has been implicated in late
Golgi transport in mammalian cells [13], and it is now
important to identify the nature of the structures that
interact with the GLDs. The GLD has also been identi-
fied by Munro and Nichols and by F.A. Barr (this issue).
Henceforth the domain shall be called the ‘GRIP’ domain.
Materials and methods
Analysis of databases for sequences related to the p230 GLD
Databases were searched for sequences related to the 98 amino-acid
carboxy-terminal domain of p230 using the NCBI BLAST family of pro-
grams. C. elegans (Sanger Center) and S. cerevisiae (NCBI) protein
sequences related to the p230 carboxy-terminal domain were identified
by analysis of both protein and genomic databases. A partial sequence
of the p230-related human protein, termed GCC1p, was initially identi-
fied within an EST cDNA clone, c-2ae12 (Genbank accession number
Z46205). Searches for contiguous nucleic-acid sequences located the
identical sequence within a human genomic cosmid g1572c101
(Genbank accession number AC000357). This genomic sequence
was then analysed for putative genes using the Nucleotide Analysis
Software maintained by the Computational Genomics Group at the
Sanger Center. A 633 amino-acid open-reading frame was predicted.
Coiled-coil predictions were performed using the COILS program [14].
Predictions from the COILS program containing stretches of 21 or
more amino acids with a probability greater than 0.5 were considered
significant. ClustalX was used for multiple alignments of protein
sequences [15]. The vector pEGFP-C1 (Clontech) was used for GFP
constructs. Transfections of COS cells, immunofluorescene and
immunoblotting were carried out as described [1,4].
Supplementary material
A background section and additional methodological detail is pub-
lished with this paper on the internet. 
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Figure 4
GFP–p230-GLD and GFP–golgin-97-GLD displace endogenous p230
from Golgi membranes at high levels of expression. Confocal
immunofluorescent images of transfected COS cells expressing high
levels of (a,b) GFP–golgin-97-GLD, (c,d) GFP–p230-GLD, or
(e,f) GFP–p230-GLD with the tyrosine at position 4 of the minimum
targeting sequence substituted with alanine. Cells were fixed in
paraformaldehyde 48 h after transfection, then permeabilised and stained
for endogenous p230 using affinity-purified human anti-p230 antibody
followed by TRITC-conjugated anti-human immunoglobulin. The same
fields are shown for (a,c,e) GFP fluorescence and (b,d,f) endogenous
p230 staining. The arrows indicate GFP-positive cells.
GFP fluorescence Endogenous p230
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Background
Many resident Golgi proteins have been described that
are specifically associated with the cytoplasmic face of
Golgi membranes. These include matrix proteins, Golgi-
localised cytoskeletal-associated proteins and proteins
associated with the machinery of vesicular transport [S1].
Many of these peripheral membrane proteins recycle
between the cytoplasm and Golgi membranes. In most
cases, however, the basis for the specific membrane locali-
sation has not been defined.
Using anti-Golgi autoantibodies from a patient with Sjö-
gren’s syndrome, we have previously identified a
230 kDa peripheral membrane protein, p230, specifically
associated with vesicles budding from the TGN [S2–S4].
Under the regulation of G proteins, p230 recycles
between the cytosol and TGN membranes. The pre-
dicted p230 protein is highly hydrophilic, which is consis-
tent with it being a peripheral membrane protein, and it
contains a very high frequency of heptad repeats (85% of
the polypeptide), characteristic of α helices that form
dimeric coiled coil structures [S3]. A number of other
Golgi autoantigens have been described which are also
peripheral membrane proteins with extensive coiled-coil
regions [S5,S6]; these include golgin-245, which is related
to p230 [S7].
The localisation of p230 specifically to TGN membranes
indicates the presence of a specific targeting sequence.
We have recently shown that the non-coiled-coil carboxy-
terminal domain of p230 is necessary and sufficient for
Golgi targeting [S8]. Here, we report a family of
hydrophilic proteins from lower and higher eucaryotes
that contain extensive coiled-coil domains and have a
similar Golgi localisation sequence to p230.
Supplementary materials and methods
Cell culture and transfection
Cell lines were maintained in exponential growth as described [S2].
COS cells were transiently transfected using FuGene 6 transfection
reagent (Boehringer Mannheim), according to the manufacturer’s
instructions. Immunofluorescence analyses of transfected cells were
performed 48 h after transfection.
Antibodies
Affinity-purified human autoantibodies to p230 were obtained from a
column of recombinant glutathione-S-transferase–p230 fusion protein
and recognised epitopes between residues 1260–1490 of p230 [S2].
Rabbit polyclonal antibodies to β-COP were generated to the EAGE
peptide [S9]. The monoclonal antibody (100.3) specific for γ-adaptin
was obtained from Sigma. Conjugates were obtained from either
Silenus Laboratories or Dako Corporation.
GFP constructs
The carboxy-terminal, non-coiled-coil, GLDs are as follows: p230, 98
amino acids; golgin-97, 87 amino acids; GCC1p, 70 amino acids; and
Imh1p, 86 amino acids. All sequences were amplified by PCR. For the
p230 GLD domain, pSVT7–p230 was used as template [S3,S8]; for
golgin-97 and GCC1p, HeLa cDNA, generated from total RNA, was
used as template; and for Imh1p, S. cerevisiae genomic DNA was
used as template. Products were confirmed by sequencing. Each
domain was fused to the carboxyl terminus of GFP by cloning the PCR
products into either the EcoRI site or the EcoRI/BamHI sites of the
green fluorescent protein (GFP) vector, pEGFP-C1 (Clontech). Muta-
genesis of the chimeric GFP constructs was carried out using inverse
PCR mutagenesis [S10]. All constructs were verified by sequencing.
Immunofluorescence 
Cells were fixed in 4% paraformaldehyde for 15 min, after which time
free aldehyde groups were quenched in 50 mM NH4Cl/PBS, and the
cells permeabilised with 0.1% Triton X-100 in PBS for 4 min. Alterna-
tively, cells were fixed in methanol at –20°C for 5 min. Cell monolayers
were incubated with PBS containing 5% fetal calf serum (PBS/FCS)
for 20 min to reduce non-specific binding. Monolayers were then incu-
bated with antibodies as described [S4,S8], mounted in mowiol, and
examined by confocal microscopy using a Bio-Rad MRC-1024
imaging system.
Immunoblotting
Immmunoblotting of transfected COS cells was carried out as previ-
ously described [S4] using anti-GFP antibodies (Boehringer-
Mannheim) at 0.4 µg/ml.
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